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Abstract 
This study’s aim was to discover the outcomes associated with massive honeybee 
envenomation. Additionally, we wanted to observe what trends might be seen with regard to 
outcomes in patients with comorbidities and those without. Honeybees belong to the insect 
family of Hymenoptera, which includes wasps, yellow jackets and hornets. Hymenoptera are 
responsible for more deaths than any other venomous insects and pose a risk to the public due 
to the emergence of well-established populations of Africanized honeybees. These honeybees 
are prevalent in southwestern states such as Arizona. Africanized bees are more aggressive and 
take less to provoke stings than non-hybridized bees, and mass envenomations can cause fatal 
accidents. This study was a retrospective review of patient charts based on ICD-9 and ICD-10 
records indicating massive honeybee envenomation and screened to include only patients 
meeting our inclusion criteria of ≥ 50 stings over a 10 year period at Banner – University 
Medical Center Phoenix. Patients were enrolled from charts between January 1, 2007 and 
October 20, 2016. 25 total patients were included and epidemiological, clinical, and therapeutic 
data were obtained compared for noticeable trends in the data with regard to demographic 
data and comorbidities. The 25 patients ranged in age from 16 to 82 years old. Total number of 
stings varied from an estimated 50 stings, to over 1000. The majority of patients were 
estimated to have been stung by between 100 to 500 bees representing thirteen patients 
(52%). Four patients (16%) had a history of CAD, fourteen patients had hypertension (56%), 
nine patients had diabetes (36%), and one patient had asthma. In terms of outcomes, five 
patients (20%) required intubation for airway management, two patients were dialyzed (8%), 
and the average length of stay was 84.2 hours over the course of hospital admission. Our 
results showed that there was no obvious trend in the outcomes of patients with and without 
CAD, asthma, hypertension, and diabetes. Notable trends were primarily seen in the total 
number of stings inflicted. In patients with a greater number of stings, the total length of stay 
increased dramatically. Number of stings also seemed to indicate a greater risk of requiring 
intubation as well. Finally, creatine kinase levels were also markedly elevated in patients with a 
higher sting count, supporting prior work done regarding the effect of mass envenomations 
with resulting rhabdomyolysis. This research supports that fact that ultimately the biggest 
determinant of a patient’s clinical course is the number of stings that they present with. It 
seems safe to assume that a mass envenomation on the scale of hundreds to thousands of 
stings will greatly increase the chance that this particular patient is going to have prominent 
rhabdomyolysis, be at greater risk of requiring advanced airway measures such as intubation, 
and be admitted to the hospital for a longer period. Future work would be enhanced by 
implementing a multicenter study to increase the power of the study to allow for statistical 
comparisons to be made to create an opportunity to delineate potential differences in 
outcomes based on comorbid conditions.   
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Introduction 
Honeybees belong to the insect family of Hymenoptera, which also includes wasps, yellow 
jackets and hornets. The stings from these insects can cause a range of clinical scenarios from 
mild symptoms to severe systemic reactions [4]. Massive honeybee envenomation by hundreds 
or even thousands of bees can lead to death due to the toxic effects of such a large quantity of 
venom [9]. Hymenoptera are responsible for more deaths than any other venomous insect [6, 
11]. Massive honeybee envenomation poses a risk to the public due to the emergence of a well-
established population of Africanized honeybees, especially in the southwestern states such as 
Arizona. Africanized bees are more aggressive and take less to provoke stings than non-
hybridized bees, and mass envenomations can cause fatal accidents [10, 13]. The venom 
produced by the honeybees contains melittin, which is known for its lytic activity and 
cardiotoxicity on mammalian hearts [12]. Phospholipase A2 is another major component of bee 
venom and, along with melittin, can cause tissue damage including hemolysis and 
rhabdomyolysis [5, 8, 10]. Our retrospective clinical study aims to evaluate the outcomes 
following massive honeybee envenomation, paying particular attention to patients with pre-
existing medical conditions and whether these are associated with a more severe emergency.   
Coronary Artery Disease and Asthma comorbidities in massive envenomation  
Studies have found that bee venom can have a direct toxic effect on the heart by inducing 
vasoconstriction, platelet aggregation and even thrombosis [7]. In one case, a 58-year-old 
woman reported chest tightness among other symptoms after being stung by 300 bees. Testing 
revealed ECG abnormalities along with a positive troponin I, and the patient was treated for 
angina until tests returned to normal. A study by Gueron et al. also discussed the effects of 
hymenoptera venom on cardiovascular health, mentioning ECG changes and rhythm 
abnormalities [6]. 
Another study highlighted the potential for myocardial ischemia following multiple bee stings, 
even in patients with normal coronary arteries. The causes of myocardial injury may be related 
to endothelial dysfunction, as well as the potential for thrombosis leading to myocardial 
ischemia, specifically in the coronary arteries [3, 13]. In our study we are interested in 
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determining the outcome of patients with a massive envenomation who had a prior diagnosis 
of coronary artery disease and how these patient outcomes might vary compared to those 
without an underlying cardiovascular pathology. Studies have also discussed various systemic 
reactions to honey bee envenomation including respiratory problems, which can occur in 0.3 – 
7.5% of the population. These reactions can be life threatening and are typically IgE antibody 
mediated via reaction to honeybee venom [3]. Our study also aims to determine whether 
patients with a pre-existing respiratory condition such as asthma are more susceptible to a 
severe reaction following a massive envenomation. 
Hemolysis  
Various studies have included hemolysis as a symptom of envenomation by honeybees. 
Hemolysis is thought to be caused by components of honeybee venom including melittin and 
phospholipase A2, causing intravascular hemolysis due to cell membrane disruption [1]. The 
resulting hemolysis can be a contributing factor in renal failure and commonly occurs with 
other systemic effects including rhabdomyolysis [2, 4, 8], and could even be related to episodes 
of hemorrhage [3]. Hemolysis and the resulting hemoglobunuria and hemoglobinemia should 
be monitored in patients [9], and remains an important aspect to consider when treating the 
systemic effects of honeybee envenomation.  
Rhabdomyolysis  
Previous studies have shown that large quantities of venom can induce rhabdomyolysis due to 
the direct toxic effects of venom components, notably melittin and phospholipase A2 on cell 
membranes [13]. In one study an adolescent boy was stung 700 times while walking in the 
woods. He presented at the ER and was treated acutely and discharged within hours with 
normal vitals and the absence of other abnormalities. However, after 8 hours the patient 
returned to the ER in a worsened condition and was admitted, spending 6 days in the hospital. 
He had high creatinine and rhabdomyolysis as a result of the massive envenomation [5]. 
Another study highlighted that even a few stings can lead to rhabdomyolysis which was the 
case for a 34-year-old male who spent 5 days in a hospital with an elevated CPK due to 
honeybee venom induced rhabdomyolysis. Although a rare symptom of envenomation it is 
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important to recognize the potential for rhabdomyolysis especially in efforts to protect renal 
function by initiating early treatment [4]. 
Renal insufficiency  
Previous research has shown that massive envenomation by honeybee stings have induced 
acute renal failure. In a study by Grisotto, et al., after injecting rats with Africanized honeybee 
venom, acute renal failure occurred via vasoconstriction of renal vessels, tubular toxicity and 
rhabdomyolysis. The main component of honeybee venom – melittin is likely the cause due to 
its effects on vascular endothelium, smooth muscle cells, arachidonic acid release, and the 
release of other vasoactive substances [1, 2]. 
Another report describes a 17-year-old Brazilian boy who was hospitalized after being stung by 
1500 bees. Labs revealed high levels of creatinine and urea consistent with acute renal failure. 
Another child in this same report was stung 600 times and initially presented with high levels of 
creatinine and urea. In both cases the patient was admitted and remained in the hospital until 
kidney function returned to normal before being discharged [2]. These cases stress one of the 
more severe complications that can occur by massive honeybee envenomation and recognizing 
this event is crucial in the treatment and management of these events.  
Length of stay 
In a particular study regarding the treatment strategies for Africanized honeybee stings, 
patients who had suffered between 20 and 500 stings remained in the hospital for an average 
of three and a half days [13]. Length of stay will be an important factor to consider in our study 
while we examine the outcomes. Length of stay seems to vary depending on the individual 
presentation and the number of stings the patient presents with.  
Number of stings  
Research suggests that when the number of stings is less than 50, and the patient in question is 
not hypersensitive to bee venom, survival is very favorable with proper treatment [10]. 
Systemic toxicity is estimated to require a minimum of 50 stings in adults, and although rare, 
deaths via massive envenomation tend to occur between 500 and 1200 stings [5, 9, 10]. Betten 
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et al. has recommended that an adult with ≥50 stings and a child with more than one sting per 
kg of body weight constitutes observation for possible delayed toxicity effects, and monitoring 
of labs – particularly CPK levels [5]. Another report detailed recommendations for a 24-hour 
hospitalization period for pediatric patients and elderly patients with greater than 50 stings due 
to the potential for a delayed toxic reaction. A 6-hour observation was suggested for all other 
patients without symptoms other than pain [8]. 
Rationale  
Various studies stress the importance of additional research required to fully elucidate the 
effects and treatment strategies for massive envenomations and the proper responses for 
emergency treatment [5, 8,] One study cited the “scant and variable” data available on the 
outcomes of massive envenomations [9]. Another study also described the importance of 
understanding the course of illness so that patients are not discharged prematurely only to 
return with a delayed onset toxic reaction [5]. There are also few reports on the cardiovascular 
effects after hymenoptera stings [6]. In reviewing the literature on massive honeybee 
envenomation it is clear that the information is limited. There does not seem to be a 
comprehensive review of a large set of patients who experienced massive envenomation, 
particularly patients in the United States. Most of the available literature is either composed of 
case reports or only study a handful of patients. By performing a retrospective review of the 
charts of patients who were admitted to Banner University Medical Center Phoenix for the 
diagnosis of massive honeybee envenomation, we could consolidate information regarding 
patient age, condition, health, and the outcomes of their envenomation. Using this information 
we can describe the treatment strategies provided and potentially highlight differences in 
individuals with pre-existing cardiovascular or respiratory conditions.   
Our retrospective clinical study asks the following: what outcomes are associated with 
massive honeybee envenomation? Additionally, what trends might be seen with regard to 
outcomes in patients with comorbidities and those without. The comorbidities evaluated 
include: asthma, coronary artery disease, hypertension, and diabetes. Outcomes measured 
after massive envenomation include: acute kidney injury, rhabdomyolysis, hemolysis, need for 
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intubation or dialysis, and total length of hospital stay. It is our hope that further insights into 
the outcomes of mass envenomations may shed some light on major trends in the hospital 
course, and whether any trends are noticed in patients with comorbidities. The current 
literature on mass envenomations is often limited to various case reports, and the lack of larger 
scale studies is also a motive for our research. It is hoped that this will contribute to our 
understanding of the effects of a toxic venom load as well as have the potential to anticipate 
clinical sequelae, especially in vulnerable patient populations.  
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FIGURE 1. Africanized honeybees have become well established in many southwestern states 
including Arizona, Nevada, New Mexico, Texas, southern California, Oklahoma, and even as far 
as Florida. (U.S. map of the spread of Africanized honey bees per year (1990 to 2011). From the 
Agricultural Research Service, (USDA 2011). Last modified: 06/26/2018.) 
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Methods & Materials 
This study was a retrospective analysis of patient charts based on ICD-9 and ICD-10 records 
indicating massive honeybee envenomation. Inclusion criteria were the following: all patients 
admitted to Banner – University Medical Center Phoenix between January 1, 2007 and October 
20, 2016 with a diagnosis of massive honeybee envenomation. Exclusion criteria were: patients 
with less than 50 stings. Records were obtained through electronic medical records and any 
paper charts available for the selected time period. Over 500 charts were screened to exclude 
other forms of envenomation (scorpions, snakes, wasps, etc) as well as single bee stings 
resulting in anaphylaxis. A total of 25 patients met criteria and were included in the study. Each 
patient’s chart was reviewed and de-identified information was collected in data abstraction 
sheets including epidemiological, clinical, and therapeutic data. The data was then transferred 
to a master list and each chart was assigned a unique identifier. Variables including age, weight, 
and past medical history were obtained for each patient. Outcomes were recorded based on 
patient’s initial presentation, admission period, and discharge. Length of stay, and interventions 
such as intubation and need for dialysis were obtained through the chart review. Mean values 
were obtained for laboratory results during three periods of admission: presentation, 
peak/nadir, and discharge. Descriptive statistics were used to display the data collected for 
demographics and outcomes. The study sponsor was Banner – University Medical Center 
Phoenix, Medical Education, and Medical Toxicology Fellowship. The study received approval 
from the Banner Health IRB – Phoenix Panel.  
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Results 
The 25 patients ranged in age from 16 to 82 years old, averaging 60.5 years, with a mean 
weight of 79.9kg.  Fifteen (60%) were male, ten were female. Total number of stings varied 
from an estimated 50 stings, to over 1000. The majority of patients were estimated to have 
been stung by between 100 to 500 bees representing thirteen patients (52%). Four patients 
(16%) had a history of coronary artery disease, fourteen patients had hypertension (56%), nine 
patients had diabetes (36%), and one patient (4%) had asthma. In terms of outcomes five 
patients (20%) required intubation for airway management, two patients were dialyzed (8%), 
and the average length of stay was 84.2 hours over the course of hospital admission. 
Laboratory values for creatine kinase at their peak show 11 patients (44%) with levels over 1000 
U/L. Peak creatinine was greater than 2.0mg/dL in six (24%) patients, while hemoglobin only 
dropped below 8.0g/dL in two (8%) patients. Table 1 summarizes these data, including values 
for Hgb, CK, and Creatinine values at presentation to the hospital as well as discharge values. 
Since this study was too small to statistically compare the outcomes with the continuous 
variables obtained, descriptive statistics were used to present the results. Table 2 and 3 show 
the results obtained for outcomes in relation to patient demographics and comorbid 
conditions. 
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Table 1. Demographics & Outcomes 
Variables Values N=25 
   
Age, years (mean, SD) 60.5 (15.3) 
Gender (male, %) 15 (60.0) 
Weight, kg (mean, SD) 79.9 (18.4) 
Stings (n, %)   
50 2 (8.00) 
51 – 100 8 (32.0) 
101 – 500 13 (52.0) 
501 - 1000+ 2 (8.00) 
CAD (yes, %) 4 (16.0) 
Asthma (yes, %) 1 (4.00) 
Hypertension (yes, %) 14 (56.0) 
Diabetes Mellitus (yes, %) 9 (36.0) 
Outcomes (yes, %)   
    
Hgb < 8.0 Presentation 1 (4.00) 
Hgb < 8.0 Nadir 2 (8.00) 
Hgb < 8.0 Discharge 0 (0.0) 
    
CK > 1000 Presentation 3 (12.0) 
CK > 1000 Peak 11 (44.0) 
CK > 1000 Discharge 8 (32.0) 
    
Creatinine > 2.0 Presentation 4 (16.0) 
Creatinine > 2.0 Peak 6 (24.0) 
Creatinine > 2.0 Discharge 4 (16.0) 
    
Intubated (yes, %) 5 (20.0) 
Dialysis (yes, %) 2 (8.00) 
Total LOS, hours (mean, SD) 84.2 (118.7) 
 
Table 1: Patient Demographics variables and outcomes among all patients with mass 
envenomations. 
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Table 2 Demographics/Comorbidities and values for Hemoglobin, Creatine Kinase, and Creatinine 
  Hemoglobin CK Level Creatinine 
Variables Pres. Nadir Discharge Pres. Peak Discharge Pres. Peak Discharge 
  Mean (g/dL) Mean (U/L) Mean (mg/dL) 
Gender                    
Female 12.8 11.3 11.5 247 1644 2551 1.36 1.36 1.11 
Male 14.9 11.8 12.5 4068 10236 2199 2.29 2.65 1.97 
Stings                 
50 14.2 11.4 11.4 116 125 125 1.33 1.35 1.15 
51 – 100 15.1 13.9 13.5 511 572 397 1.08 1.19 0.95 
101 – 500 13.9 11.8 11.8 3425 990 3333 2.39 2.56 1.89 
501 - 1000 10.6 8.85 9 301 24102 3250 0.8 3.95 3.08 
CAD                    
No 14.2 11.6 12.1 2987 8972 2621 1.77 2.11 1.59 
Yes 13.3 11.5 12.5 555 3330 1110 2.3 2.3 1.83 
Asthma                 
No 13.9 11.5 12 2686 8555 2416 1.85 2.13 1.63 
Yes 17.6 14.5 14.5 814 814 682 2.1 2.1 1.44 
Hypertension                    
No 13.5 10.1 11.3 5695 12564 1762 2.45 2.98 1.67 
Yes 14.4 12.6 12.8 601 5184 2685 1.46 1.47 1.59 
Diabetes                 
No 13.9 10.9 11.7 3614 11794 2554 2.07 2.44 1.43 
Yes 14.3 12.6 12.9 519 3016 1974 1.5 1.59 1.67 
Table 2. shows the comparison of the continuous variables with the laboratory values 
for hemoglobin, creatine kinase, and creatinine during hospital admission. 
Presentation, peak/nadir, and discharge values for each lab are displayed using the 
mean.   
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Table 3. Demographics/Comorbidities with relation to Intubation or 
Dialysis, and Length of Stay 
Variables Intubation Dialysis Total Length of 
Stay 
  N, % N, % Mean (hrs) 
Gender        
Female 1 (10.0) 0 (0.0) 44.3 
Male 4 (26.7) 2 (13.3) 110.7 
Stings        
50 0 (0.0) 0 (0.0) 22.3 
51 – 100 1 (12.5) 0 (0.0) 28.6 
101 – 500 2 (15.4) 1 (7.69) 104 
501 - 1000 2 (100.0) 1 (50.0) 236.5 
CAD        
No 5 (23.8) 2 (9.52) 85.2 
Yes 0 (0.0) 0 (0.0) 78.6 
Asthma        
No 5 (20.8) 2 (8.33) 87.1 
Yes 0 (0.0) 0 (0.0) 12.5 
Hypertension        
No 3 (27.3) 2 (18.2) 121.2 
Yes 2 (14.3) 0 (0.0) 55 
Diabetes        
No 4 (25.0) 2 (12.5) 99.6 
Yes 1 (11.1) 0 (0.0) 56.6 
 
Table 3. shows the comparison of the continuous variables and the instances of 
intubation, dialysis, and length of stay.  
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Discussion 
The primary question asked was what outcomes are associated with massive honeybee 
envenomation and can we see trends in outcomes between patients with comorbid conditions 
and those without? Our results show that there were no obvious trends with respect to the 
outcomes seen in patients with and without CAD, asthma, hypertension, and diabetes. Because 
of the small sample size, any real differences in outcomes would be impossible to detect 
statistically, and ultimately we were limited by an underpowered study. There were, however, 
some trends noticed in outcomes with relation to demographic data, primarily seen in the total 
number of stings inflicted. In patients with a greater number of stings, the total length of stay 
increased dramatically. Patients who had 50 to 100 stings had an average length of stay of 
about 28 hours, but in patients in the range of hundreds of stings the average stay went up to 
104 hours, and with stings over 500, the average length of stay was 236 hours. This highlights 
the importance of the impact of the total toxic venom load in mass envenomations of this 
caliber. While again being unable to report any statistical differences using our data, there was 
also a clear trend towards requiring intubation as an intervention as the number of stings 
became greater.  
With regard to laboratory outcomes, peak creatine kinase measurements were markedly higher 
in patients with a greater number of stings. This finding supports other literature confirming 
rhabdomyolysis as a common outcome of massive envenomation. A component of bee venom 
– melittin – is thought to cause rhabdomyolysis via the mechanisms by which it inserts itself 
into the phospholipid bilayer of cell membranes, ultimately causing cell disruption. 
Phospholipase A2 further damages cell membranes and may also play a role in rhabdomyolysis. 
Again, total number of stings seems to be the primary difference in the severity of 
rhabdomyolysis, as evidenced in Table 2 – the patients on discharge who had more stings 
(>100), still have a greater CK level than patients with fewer total stings. Peak creatinine was 
also found to be higher in male patients. The reason for this difference could be an issue 
regarding total body mass, in which patients with more muscle mass may be slightly more 
affected by the resulting rhabdomyolysis and myoglobinemia after a mass envenomation. This 
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would in turn affect the function of the kidneys resulting in an acute kidney injury while raising 
creatinine levels. Age did not appear to play a significant factor in any of the outcome variables 
measured, with no obvious trends observed. 
This project supports that fact that ultimately the biggest determinant of a patient’s clinical 
course is the number of stings that they present with. It seems safe to assume that a mass 
envenomation on the scale of hundreds to thousands of stings will greatly increase the chance 
of significant rhabdomyolysis, risk of requiring intubation, and greatly increased hospital stay. 
This research project is not without its weaknesses, of which the primary concern is the total 
number of patients included in this study. Even having gone back through 10 years worth of 
patient charts at a major institution in a southwestern state affected by Africanized honeybees, 
only 25 patient charts met our inclusion criteria. This highlights the rarity of this type of clinical 
scenario, but also supports why research in this area is important for when these events do 
occur. Because this study was limited by a small sample size, the power of this research would 
be greatly enhanced by the inclusion of many more patient samples to help delineate if any 
comorbid conditions may in fact play a significant role in outcomes.  
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Future Directions 
Future research could use a multi-institutional approach to capture a larger pool of patients 
needed to perform a more robust statistical analysis on outcomes and whether in fact 
comorbid conditions could play a significant role in outcomes. New research could also 
separate pediatric patients to further delineate the work to include age as a predisposing factor 
to determine whether comorbid conditions plays a role in these distinct populations.  
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Conclusions 
 In summary, our research has supported prior work on massive envenomation with 
regard to envenomation severity. In patients high a higher sting count, the outcomes had a 
clear trend towards worsened laboratory values as well as greater risk of interventions. We 
found that ultimately the largest determinant of a patient’s clinical course was the number of 
stings inflicted during the bee attack. When patients are stung by hundreds and even thousands 
of bees, the likelihood of resulting rhabdomyolysis, advanced airway measures, and lengthened 
hospital stay increased based on our findings. This study helps add to a limited fund of 
knowledge regarding mass envenomation scenarios, and sheds light on the clinical course of 
patients, especially those in severe envenomation. While being limited by an underpowered 
study, this information adds to a field of research that is lacking larger robust studies, and may 
help solidify the importance of how sting number may impact a patient’s clinical course.   
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